HHLR ADVISORS, LTD.HHLR ADVISORS, LTD.

Institutional investor · Portfolio as of Q3 2021

SEC EDGAR SourceSEC Filings

Top Holdings85 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction
ONCONC
ADR

BEIGENE LTD-ADR

5.5M$2B26.0%$134.02+169.77%
12 qtrssince 2018-Q4
Unchanged
0
LEGNLEGN
ADR

Legend Biotech Corp. Sponsored ADR

11.1M$558.9M7.3%$46.85+0.77%
6 qtrssince 2020-Q2
Increased
99
NBPNBP
ADR

NOVABRIDGE BIOSCIENCES

7.2M$520.7M6.8%$47.24+50.76%
5 qtrssince 2020-Q3
Increased
66

ON HLDG AG

16M$481.3M6.3%$30.900.00%
1 qtr
New
97
JDJD
ADR

JD.COM INC-ADR

4.8M$344.4M4.5%$49.36+31.66%
12 qtrssince 2018-Q4
Increased
72

SALESFORCE.COM INC

1.3M$340.2M4.4%$192.71+38.68%
7 qtrssince 2020-Q1
Increased
63
IQIQ
ADR

IQIYI INC

38.6M$310.3M4.1%$18.39-57.97%
12 qtrssince 2018-Q4
Unchanged
0
PDDPDD
ADR

PDD HOLDINGS INC

2.8M$254.6M3.3%$34.04+161.60%
12 qtrssince 2018-Q4
Decreased
0

BRIDGEBIO PHARMA INC

5.4M$251.3M3.3%$28.25+68.54%
10 qtrssince 2019-Q2
Unchanged
0

DOORDASH INC - A

1.2M$246.4M3.2%$141.95+45.01%
4 qtrssince 2020-Q4
Unchanged
0

CYTEK BIOSCIENCES INC

8.8M$187.5M2.5%$20.960.00%
1 qtr
New
79

BEAM THERAPEUTICS INC

1.4M$126M1.6%$18.00+50.56%
7 qtrssince 2020-Q1
Decreased
0

MONDELEZ INTERNATIONAL INC-A

1.9M$108.3M1.4%$33.70+57.03%
12 qtrssince 2018-Q4
Unchanged
0
BABABABA
ADR

ALIBABA GROUP HOLDING-SP ADR

713,400$105.6M1.4%$213.40-34.71%
3 qtrssince 2021-Q1
Unchanged
0
SESE
ADR

SEA LTD-ADR

330,000$105.2M1.4%$311.780.00%
1 qtr
New
68

Erasca, Inc.

4.7M$100.2M1.3%$19.840.00%
1 qtr
New
68
VIPSVIPS
ADR

VIPSHOP HLDGS LTD

9M$99.9M1.3%$19.34-46.58%
3 qtrssince 2021-Q1
Unchanged
0

GOSSAMER BIO INC

7.4M$93.3M1.2%$16.82-21.84%
11 qtrssince 2019-Q1
Unchanged
0
BEKEBEKE
ADR

KE HOLDINGS INC-ADR

5M$91.5M1.2%$62.02-73.09%
5 qtrssince 2020-Q3
Unchanged
0

PLAYTIKA HLDG CORP

3.3M$90.6M1.2%$23.03-0.35%
3 qtrssince 2021-Q1
Unchanged
0
$7.6B
AUM
85
Positions
Q3 2021
Filing
Rating · 2.0
Quarterly Portfolio Change
+47%Q2'20$10.9B+21%Q3'20$13.2B-5%Q4'20$12.6B-20%Q1'21$10.1B-4%Q2'21$9.7B-21%Q3'21$7.6B
Activity profile
$ moved · Q3'21
New24%Increased13%Decreased35%Exited29%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 1.2 years
<1Q21%1-4Q18%1-2Y27%2Y+34%

HHLR ADVISORS, LTD. manages $7.6B across 85 positions as of Q3 2021. Top holdings: ONC (26.0%), LEGN (7.3%), NBP (6.8%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 2/5.0.

Q3 2021 Summary

Active quarter - 21 new positions, 25 exits, 5 increased. Top move: LEGN (INCREASED, conviction 99). Portfolio: $7.6B across 85 positions.

Top holdings by portfolio weight

Total AUM$8B
ONC25.98%
LEGN7.31%
NBP6.81%
ONON6.29%
JD4.50%
CRM4.45%
IQ4.06%
PDD3.33%
BBIO3.29%
DASH3.22%
Other2.45%

Portfolio allocation by GICS sector

Sectors9
Healthcare56.57%
Consumer Cyclical25.04%
Technology6.64%
Communication Services6.55%
Consumer Defensive1.59%
Unknown1.26%
Real Estate1.20%
Financial Services1.05%
Industrials0.10%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Healthcare, Consumer Cyclical
Compare DNA across all funds
7-dimension quality assessment
Below Average(2.0 / 5.0)
Track RecordNo data
Conviction42
Concentration100
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

No active accumulation streaks detected for this filer.

Streaks require 2+ consecutive quarters of increased positions in the most recent period.

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used